Armistice Capital’s Charles River Laboratories CRL Stock Holding History

Armistice Capital’s Portfolio CRL Stock Details CRL Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$302K	Buy
2024 Q3	–	Sell
2024 Q2	$24.6M	Buy
2024 Q1	$18.9M	Buy
2023 Q4	$8.51M	Sell
2023 Q3	$30.6M	Buy